Cancer Biomarkers Market, By Biomarker Type (Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers and Metabolic Biomarkers), By Cancer Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
|
Report ID
AV2919
|
Published Date
December 2024
|
Pages
393
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Cancer Biomarkers Market size was valued at USD 28,928.41 million in 2023, expanding at a CAGR of 12.90% from 2024 to 2032.
The Cancer Biomarkers Market refers to identifying and utilizing biological molecules that indicate the presence of cancer in the body, aiding in diagnosis, prognosis, and therapy selection. Increasing demand for personalized medicine, advances in omics technologies, and growing investments in cancer research are boosting market growth. The rising prevalence of cancer globally, with an estimated 19.3 million new cases reported in 2020, underscores the need for efficient diagnostic tools. However, the high costs of biomarker validation and stringent regulatory requirements pose challenges to market expansion. Emerging opportunities lie in developing non-invasive liquid biopsy techniques, which are gaining attention for their potential to improve early cancer detection and monitoring.
Cancer Biomarkers Market- Market Dynamics
Rising Demand for Personalized Medicine Fuels Growth in the Cancer Biomarkers Market
Rising demand for personalized medicine is significantly driving the growth of the Cancer Biomarkers Market as it allows for more targeted and effective cancer treatments. Organizations like the National Institutes of Health (NIH) and the World Health Organization (WHO) emphasize the importance of biomarkers in advancing precision oncology, especially with global cancer cases expected to rise by 47% between 2020 and 2040. For instance, the American Cancer Society has highlighted how biomarkers such as BRCA1 and BRCA2 are pivotal in assessing breast and ovarian cancer risks. Additionally, biomarker-driven therapies are increasingly being incorporated into clinical guidelines, as seen in the U.S. FDA’s approval of multiple biomarker-based treatments over the past decade. These advancements are propelling research and innovation in cancer diagnostics and treatment pathways.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CANCER BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Abbott Laboratories
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Exact Sciences Corporation
Foundation Medicine, Inc. (Roche)
GE Healthcare (General Electric Company)
Guardant Health, Inc.
Hologic, Inc.
Illumina, Inc.
Myriad Genetics, Inc.
NeoGenomics, Inc.
PerkinElmer, Inc.
Qiagen N.V.
Roche Diagnostics (F. Hoffmann-La Roche AG)
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Others
GLOBAL CANCER BIOMARKERS MARKET, BY BIOMARKER TYPE- MARKET ANALYSIS, 2019 - 2032
Genetic Biomarkers
Protein Biomarkers
Epigenetic Biomarkers
Metabolic Biomarkers
GLOBAL CANCER BIOMARKERS MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2019 - 2032
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
GLOBAL CANCER BIOMARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Diagnosis
Prognosis
Drug Discovery and Development
Personalized Medicine
GLOBAL CANCER BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Cancer Biomarkers Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Cancer Biomarkers Market Snippet by Biomarker Type
2.1.2. Cancer Biomarkers Market Snippet by Cancer Type
2.1.3. Cancer Biomarkers Market Snippet by Application
2.1.4. Cancer Biomarkers Market Snippet by Country
2.1.5. Cancer Biomarkers Market Snippet by Region
2.2. Competitive Insights
3. Cancer Biomarkers Key Market Trends
3.1. Cancer Biomarkers Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Cancer Biomarkers Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Cancer Biomarkers Market Opportunities
3.4. Cancer Biomarkers Market Future Trends
4. Cancer Biomarkers Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Cancer Biomarkers Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Cancer Biomarkers Market Landscape
6.1. Cancer Biomarkers Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Cancer Biomarkers Market – By Biomarker Type
7.1. Overview
7.1.1. Segment Share Analysis, By Biomarker Type, 2023 & 2032 (%)
7.1.2. Genetic Biomarkers
7.1.3. Protein Biomarkers
7.1.4. Epigenetic Biomarkers
7.1.5. Metabolic Biomarkers
8. Cancer Biomarkers Market – By Cancer Type
8.1. Overview
8.1.1. Segment Share Analysis, By Cancer Type, 2023 & 2032 (%)
8.1.2. Breast Cancer
8.1.3. Lung Cancer
8.1.4. Colorectal Cancer
8.1.5. Prostate Cancer
9. Cancer Biomarkers Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
9.1.2. Diagnosis
9.1.3. Prognosis
9.1.4. Drug Discovery and Development
9.1.5. Personalized Medicine
10. Cancer Biomarkers Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Cancer Biomarkers Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Cancer Biomarkers Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Cancer Biomarkers Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Cancer Biomarkers Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Cancer Biomarkers Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Biomarker Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Cancer Biomarkers Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.2. Agilent Technologies, Inc.
11.2.3. Bio-Rad Laboratories, Inc.
11.2.4. Exact Sciences Corporation
11.2.5. Foundation Medicine, Inc. (Roche)
11.2.6. GE Healthcare (General Electric Company)
11.2.7. Guardant Health, Inc.
11.2.8. Hologic, Inc.
11.2.9. Illumina, Inc.
11.2.10. Myriad Genetics, Inc.
11.2.11. NeoGenomics, Inc.
11.2.12. PerkinElmer, Inc.
11.2.13. Qiagen N.V.
11.2.14. Roche Diagnostics (F. Hoffmann-La Roche AG)
11.2.15. Siemens Healthineers AG
11.2.16. Thermo Fisher Scientific Inc.
11.2.17. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
